![Dragan Cicic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/08/2026
Dragan Cicic is currently a Member at the American Society of Hematology and Chief Development Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. since 2024.
Former positions include Director, Chief Operating & Medical Officer at Actinium Pharmaceuticals, Inc. (2012–2013), Project Director at QED Technologies International, Inc., Chief Operating & Medical Officer at Cactus Ventures, Inc. (2012–2013), Principal at British Broadcasting Corp., Chief Technology Officer at Actinium Pharmaceuticals, Inc. (2017), and Senior Vice President at KLUS Pharma, Inc. Education includes a doctorate from the University of Belgrade, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the School of Medicine (RS).
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2026 | 126.443 ( 0,06% ) | 2 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Amministratore Delegato | - |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Direttore Tecnico/Scientifico/R&S | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direttore operativo | 18/04/2013 |
KLUS Pharma, Inc.
 KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Corporate Officer/Principal | - |
British Broadcasting Corp.
 British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Consumer Services |
University of Belgrade
 University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Technologies International, Inc.
 QED Technologies International, Inc. Electronic ComponentsElectronic Technology Manufactures precision optics | Electronic Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
School of Medicine (RS)
 School of Medicine (RS) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
